Bleecker Street Research
Long/short equity, special situations

Biologix Hair: Not Worth $261 Million

Author's Note, June 30: The original version of this article contained an error in which I mistakenly suggested it was attempting to be listed on the NYSE, which has now been corrected.

Biologix Hair (OTCPK:BLGX) is a company that produces a hair loss prevention and regeneration solution. Biologix Hair Inc. is developing the Biologix Hair Therapy System, of which the core is Biologix Revive, a formula containing two pharmaceutical agents previously approved by the FDA for other purposes, and a 22-component vitamin, mineral and nutrient complex. Biologix Hair is a $261 million market company, but I believe that it is worth significantly less, in fact could be worth zero. Biologix has incurred a loss of $25,493,215 since its...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
Money back guarantee. Seeking Alpha PRO members receive a no-questions-asked refund for membership on months paid and not used. Details